Professional Documents
Culture Documents
EDITORS
DIAGNOSIS AND TREATMENT OF MITRAL VALVE DISEASE: A MULTIDISCIPLINARY APPROACH ISBN: 978-0-323824781
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical,
including photocopying, recording, or any information storage and retrieval system, without permission in writing from
the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found
at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may
be noted herein).
Notice
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any
information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences,
in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law,
no responsibility is assumed by Elsevier, authors, editors, or contributors for any injury and/or damage to persons
or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
Printed in India
Sandra V. Abramson, MD, FACC, FASE Daniel J.P. Burns, MD, MPhil Eric M. Gnall, DO
Director Staff Surgeon Director of ECMO/Acute Mechanical
Cardiovascular Imaging Center Department of Thoracic and Cardiovascular Circulatory Support
Lankenau Medical Center Surgery Main Line Health
Wynnewood, Pennsylvania; Cleveland Clinic Wynnewood, Pennsylvania
Clinical Assistant Professor Cleveland, Ohio United States
Sidney Kimmel Medical College United States
Philadelphia, Pennsylvania Scott M. Goldman, MD
United States Andrew Chatfield, MBChB Director, Structural Heart Program
Centre for Heart Valve Innovation Lankenau Heart Institute;
Michael A. Acker, MD St. Paul’s Hospital Professor of Surgery
Chief, Division of Cardiovascular Surgery University of British Columbia Thomas Jefferson University
Director, Penn Medicine Heart and Vascular Vancouver, British Columbia Wynnewood, Pennsylvania
Center Canada United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania Chunguang Chen, MD, FACC William A. Gray, MD
United States Director, Cardiovascular Imaging Chief of Cardiovascular Division
Deborah Heart and Lung Center Lankenau Medical Center and Lankenau
Tariq Ahmad, MD Browns Mills, New Jersey Institute of Medical Research
Interventional Cardiology United States Wynnewood, Pennsylvania
Geisinger Wyoming Valley Medical Center United States
Wilkes-Barre, Pennsylvania Roxanne DeStefano, BS
United States Structural Heart Therapy Consultant Lee Hafen, MD
Philadelphia, Pennsylvania Baylor Scott & White The Heart Hospital
Gorav Ailawadi, MD, MBA United States Plano, Texas
Professor and Chair United States
Department of Cardiac Surgery Steven M. Domsky, MD
University of Michigan Director, Cardiac ICU Rebecca T. Hahn, MD, FACC
Ann Arbor, Michigan Cardiology Professor of Medicine
United States Lankenau Medical Center Columbia University
Wynnewood, Pennsylvania Irving Medical Center;
Saif Anwaruddin, MD United States Director, Interventional Echocardiography
Director, Interventional Cardiology New York Presbyterian Hospital
St. Vincent’s Hospital Amber M. Edwards, MD New York, New York
Tenet Healthcare Surgeon United States
Worcester, Massachusetts Department of Cardiac Surgery
United States St. Thomas Health Rim Halaby, MD
Nashville, Tennessee Division of Cardiology
Pavan Atluri, MD United States Hospital of the University of Pennsylvania
Associate Professor of Surgery Philadelphia, Pennsylvania
Division of Cardiovascular Surgery Douglas B. Esberg, MD United States
University of Pennsylvania Director, Cardiac Electrophysiology Lab
Philadelphia, Pennsylvania Lankenau Medical Center Jason J. Han, MD
United States Wynnewood, Pennsylvania Division of Cardiovascular Surgery
United States University of Pennsylvania
Shaylyn C. Bennett, MD, MS Philadelphia, Pennsylvania
Department of Cardiovascular Surgery Clarence M. Findley, MD, PhD United States
Nationwide Children’s Hospital Baylor Scott & White The Heart Hospital
Columbus, Ohio Plano, Texas W. Clark Hargrove III, MD
United States United States Clinical Professor of Surgery
Division of Cardiovascular Surgery
Philipp Blanke, MD A. Marc Gillinov, MD University of Pennsylvania
Department of Radiology Department of Thoracic and Cardiovascular Philadelphia, Pennsylvania
St. Paul’s Hospital Surgery United States
Vancouver, British Columbia Heart and Vascular Institute
Canada Cleveland Clinic
Cleveland, Ohio
United States
v
vi CONTRIBUTORS
Lisa Hathaway Stella, MPH Samir R. Kapadia, MD, FACC Vinayak Nagaraja, MBBS, MS, MMed
Executive Director Chairman, Department of Cardiovascular (Clin Epi), FRACP, FCSANZ, FACC
Interventional Cardiology Medicine Division of Interventional Cardiology
Columbia University Irving Medical Center Cleveland Clinic Foundation Department of Cardiovascular Medicine
New York, New York Cleveland, Ohio Cleveland Clinic Foundation
United States United States Cleveland, Ohio
United States
Katie M. Hawthorne, MD, FACC Elina Khasanova, MD
Cardiology Clinical Fellow Wally Omar, MD
Lankenau Medical Center Radiology Fellow, Interventional Cardiology
Lankenau Heart Institute Center for Heart Lung Innovation Beth Israel Deaconess Medical Center
Wynnewood, Pennsylvania; St. Paul’s Hospital Boston, Massachusetts
Clinical Assistant Professor of Medicine Vancouver, British Columbia United States
Sidney Kimmel Medical College Canada
Thomas Jefferson University Yinn Shaung Ooi, MD
Woodbury, New Jersey Konstantinos P. Koulogiannis, MD Fellow, Cardiology
United States Associate Director, Cardiovascular Core Lab Lankenau Medical Center
Department of Cardiovascular Medicine Philadelphia, Pennsylvania
Mark R. Helmers, MD Morristown Medical Center United States
Division of Cardiovascular Surgery Gagnon Cardiovascular Institute
University of Pennsylvania Morristown, New Jersey Gosta B. Pettersson, MD, PhD
Philadelphia, Pennsylvania United States Vice Chairman and Professor
United States Department of Thoracic and Cardiovascular
Jonathon Leipsic, MD, FRCPC, FSCCT Surgery
Howard C. Herrmann, MD Vice Chairman Cleveland Clinic
John W. Bryfogle Jr. Professor of Department of Radiology Cleveland, Ohio
Cardiovascular Medicine University of British Columbia United States
Division of Cardiovascular Medicine Vancouver, British Columbia
Perelman School of Medicine of the Canada Duane Pinto, MD, MPH
University of Pennsylvania Associate Professor of Medicine
Health System Director for Interventional Leo Marcoff, MD Harvard Medical School;
Cardiology Director of Interventional Echocardiography Director, Cardiac Catheterization Laboratory
Hospital of the University of Pennsylvania Department of Cardiovascular Medicine Beth Israel Deaconess Medical Center
Philadelphia, Pennsylvania Morristown Medical Center Boston, Massachusetts
United States Morristown, New Jersey United States
United States
Benjamin I. Horn, DO Michel Pompeu Sá, MD, PhD
Fellow, Cardiology Gwyneth McNeill, DO Cardiovascular Surgeon
Lankenau Medical Center Fellow, Cardiology Research Assistant Professor
Wynnewood, Pennsylvania Main Line Health Lankenau Institute for Medical Research
United States Wynnewood, Pennsylvania Wynnewood, Pennsylvania
United States United States
Michael Ibrahim, MBBS, PhD
Assistant Professor of Surgery Sehrish Memon, MD Nicolas H. Pope, MD
Associate Director, Penn Mitral Program Structural Heart Fellow Assistant Professor
Division of Cardiovascular Surgery Cardiovascular and Structural Heart Disease Division of Cardiothoracic Surgery
University of Pennsylvania Lankenau Medical Center and Lankenau Medical University of South Carolina
Philadelphia, Pennsylvania Institute of Medical Research Charleston, South Carolina
United States Wynnewood, Pennsylvania United States
United States
Manju Bengaluru Jayanna, MD, MS Basel Ramlawi, MD, FACS, FACC
Cardiovascular Diseases Fellow Ryan A. Moore, MD, MS System Chief
Lankenau Medical Center Research Fellow Cardiothoracic Surgery
Wynnewood, Pennsylvania Cleveland Clinic Foundation Lankenau Heart Institute
United States Cleveland, Ohio Wynnewood, Pennsylvania
United States United States
Justin Johannesen, MD
Cardiology Fellow Carrie Redick, RN, MSN
Cardiology Director, Interventional Cardiology and
Rutgers Robert Wood Johnson Medical Structural Heart
School Atlantic Health System
New Brunswick, New Jersey Morristown, New Jersey
United States United States
CONTRIBUTORS vii
The modern era of interventional treatment of mitral valve disease similar to a “flight plan” in aviation: The pilot does not just plan on
has seen great strides, beginning in 1948. Just think, prior to June when to leave and where to go. The planning involves pre-checking
1948, the only accepted treatment for mitral valve disease was the airplane, planning the route, determining the fuel load required,
medical therapy. But all that would change in Philadelphia, PA, knowing the weather en route and, alternative airports in case of
on June 10, 1948, when Charles P. Bailey performed a successful bad weather, knowing the type of flight (visual or instrument),
surgical mitral commissurotomy, after which the patient did well and planning the proper altitude. Similarly, our experience has
for more than 35 years. Also in that same year, Dwight Harken shown us that a high degree of preparation prior to arriving in
in Boston, MA, began a successful series of that procedure the operating room or catheterization laboratory—a plan—is
which paved the way for the procedure to be performed safely likely to improve outcomes and procedural efficiency.
and effectively. The modern era of interventional treatment of The volume includes contributions from a varied team of
mitral valve disease had arrived! In September of 1960, Albert specialists: surgeons, heart failure specialists, interventional
Starr successfully implanted an artificial heart valve in the mitral cardiologists, and imaging cardiologists—perhaps the keystone of
position in a patient with mitral stenosis who had undergone the team. We are grateful for their contributions and willingness
two failed attempts at commissurotomy. Percutaneous mitral to impart their knowledge so that the next generation of
balloon valvuloplasty (MBV) was introduced in 1984 by Inoue, interventional mitral valve specialists can improve their craft and
who developed the procedure as a logical extension of surgical patient outcomes. Key to the efficient functioning of this team is
closed commissurotomy. that each member has a depth of knowledge that includes all of
We believe the time is right to assemble a contributed these specialties. That is, it is just as important for the imager to
volume to help guide physicians who seek proficiency in the understand surgical and transcatheter techniques and capabilities
most modern treatment of mitral valve disease. The volume is as it is for the surgeon and interventional cardiologist to be able to
not intended as the definitive tome on the subject of mitral valve interpret both diagnostic imaging and imaging required to treat
disease and its treatments, but, rather, a curated volume of those the mitral valve.
topics that our collective experience has proven most valuable We hope this volume helps new mitral valve program teams
for the success of the physician and the excellence of patient gain the knowledge needed for a successful start; and, for
outcomes. established programs, to improve, advance, and thrive.
Our aim is that the curated topic areas will help physicians
assemble a plan before they undertake any interventional Scott M. Goldman, MD
treatment of a patient with mitral valve disease. Not just a plan William A. Gray, MD
for which treatment would be the most appropriate for that Lankenau Heart Institute
patient, but a plan for the exact steps in that intervention. This is
ix
F OR EWOR D
The knowledge necessary to effectively practice clinical medicine center wishing to embrace best practices in the management of
is growing exponentially. This is particularly true in the area of patients with mitral valve disease in the modern era. In addition
valvular heart disease as we are witnessing transformational to sharing their own expertise, Drs. Goldman and Gray have
advancements in the epidemiology, diagnosis, assessment, and recruited an impressive cadre of world thought leaders to share
management of patients with heart valve disease. The scope of their knowledge and experience in the 29 chapters arranged
information required to deliver optimal or best clinical practice in 6 sections. These chapters provide the latest evidence on the
is demanding a “super-subspecialization” focus on individual pathogenesis, pathophysiology, clinical findings, imaging
heart valves. This is particularly true in mitral valve disease, which techniques and medical, surgical, and transcatheter therapy
is the most common type of valvular heart disease with diverse options for patients with mitral valve disease. They also give
etiologies and anatomic variants, and with rapidly evolving us practical information as to how to assemble these specialists
assessment and management strategies being introduced into into a well-functioning multidisciplinary team.
clinical practice on a seemingly constant basis. To coalesce the The term “center of excellence” is an oft used term to define
evolving expertise necessary in all areas of clinical care, it is critical centers that provide best-in-class care worthy of a reference
that dedicated mitral valve specialists, including general and heart center, but not infrequently the actual care delivered falls
failure cardiologists, imaging experts, structural interventional short of the designation. For centers that truly embrace and
cardiologists, cardiac surgeons specializing in valvular heart desire excellence in mitral valve disease management, this
disease, midlevel providers, and researchers be assembled into comprehensive resource should serve as the default manual of
effective multidisciplinary heart teams. Thus, the multispecialty how to truly achieve the desired lofty status.
mitral valve team becomes the vehicle to ensure and render As close professional colleagues of Drs. Goldman and Gray,
optimal patient care. we consider it a privilege to introduce this work to the clinical
The team at the Lankenau Heart Institute headed by Scott community caring for patients with mitral valve disease. We are
Goldman, an expert mitral valve surgeon, and Bill Gray, an proud of the expert mitral valve care delivered to patients by
equally expert mitral structural interventionalist, embody the Lankenau team and feel fortunate that they have assembled
the quintessential leadership and clinical care structure to their collective experiences to share with the rest of us in this
deliver optimal mitral valve management in their institution. superb reference manual.
Fortunately for us, they have assembled their collective
experiences and learnings into this work entitled Diagnosis and Martin B. Leon, MD
Treatment of Mitral Valve Disease. This comprehensive yet easily Michael J. Mack, MD
readable compendium serves as a “how to do it” resource for any
xi
ACKNOWLED GMENTS
We are fortunate to have begun our medical careers as the modern era of interventional
treatment of mitral valve disease had already begun. Learning from those who pioneered new
surgical procedures and interventions, we sought to move the field in a direction that would
advance the field and improve patient outcomes.
We are hopeful that this contributed volume, Diagnosis and Treatment of Mitral Valve Disease:
A Multidisciplinary Approach, will help a new generation of surgeons and cardiologists advance
the field, establishing their own successful programs, contributing to research in the field, and
advancing improved patient outcomes. We have drawn on the expert advice of today’s thought
leaders, who have made significant contributions to the understanding and betterment of the
field. We are certain that these contributions will help those seeking to start new programs or
improve existing programs. Our heartfelt thanks to all who have contributed to this volume:
Sandra V. Abramson, Michael A. Acker, Tariq Ahmad, Gorav Ailawadi, Saif Anwaruddin,
Pavan Atluri, Manju Bengaluru Jayanna, Shaylyn C. Bennett, Philipp Blanke, Daniel
J.P. Burns, Andrew Chatfield, Chunguang Chen, Roxanne DeStefano, Steven M. Domsky,
Amber M. Edwards, Douglas B. Esberg, Clarence M. Findley, A. Marc Gillinov, Eric M. Gnall,
Lee Hafen, Rebecca T. Hahn, Rim Halaby, Jason J. Han, W. Clark Hargrove III, Lisa Hathaway,
Katie M. Hawthorne, Mark R. Helmers, Howard C. Herrmann, Benjamin I. Horn, Michael
Ibrahim, Justin Johannesen, Samir R. Kapadia, Elina Khasanova, Konstantinos P. Koulogiannis,
Jonathon Leipsic, Leo Marcoff, Gwyneth McNeill, Sehrish Memon, Ryan A. Moore, Vinayak
Nagaraja, Wally Omar, Yinn Shaung Ooi, Gosta B. Pettersson, Duane Pinto, Michel Pompeu
Sá, Nicolas H. Pope, Basel Ramlawi, Carrie Redick, Evelio Rodriguez, K. Marco Rodriguez,
Roberto Rodriguez, Zach Rozenbaum, Mark J. Russo, Vishal N. Shah, Serge Sicouri, Robert
L. Smith II, Benjamin Smood, John J. Squiers, Molly Szerlip, Chidinma Tiko-Okoye, and
Per Wierup.
We also feel fortunate to be publishing the volume with the world-class science and medical
publisher, Elsevier, whose team saw the importance of the work and carried it through to completion.
First, we thank Jessica L. McCool, who recognized the importance of contributing to new works
in a still-emerging field and signed the volume to the Elsevier portfolio. We thank Anne E. Snyder,
who deftly assumed editorial responsibility after the volume was underway and made certain that
the volume was developed in a consistent, high-quality manner. Gayathri S, our production
project manager, deserves a special thanks for her attention to detail and for ensuring that all
contributions were reviewed by contributors and readied for production.
Finally, we thank Main Line Heart Institute, whose focus on providing the best patient care,
outcomes, and options has supported our work and research.
Scott M. Goldman, MD
William A. Gray, MD
xiii
CONTENTS
xv
VIDEO CONTENTS
xvii
xviii VIDEO CONTENTS
Language: English
E. ALEXANDER POWELL